北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学精神卫生研究所  > 期刊论文
学科主题: 精神卫生
题名:
Fluvoxamine in the treatment of depression: results from a Chinese population
作者: Gu, NF1; Cai, ZJ1; Liang, S1; Zhou, TX1; Xu, JM1; Zhang, XB1; Wu, WY1; Ming, L1
关键词: depression ; fluvoxamine ; selective serotonin reuptake inhibitor ; china
刊名: PRIMARY CARE PSYCHIATRY
发表日期: 2004
DOI: 10.1185/135525704X10746
卷: 9, 期:3, 页:89-94
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Medicine, General & Internal ; Psychiatry
研究领域[WOS]: General & Internal Medicine ; Psychiatry
关键词[WOS]: SEROTONIN TRANSPORTER GENE ; MAJOR DEPRESSION ; DOUBLE-BLIND ; MEDICAL OUTCOMES ; PAROXETINE ; OUTPATIENTS ; MANAGEMENT ; FLUOXETINE ; DISORDERS ; COMMUNITY
英文摘要:

This multicentre, open, post-marketing study was conducted to investigate the efficacy and tolerability of fluvoxamine in patients with depressive disorders in China. A total of 120 Chinese patients were treated with fluvoxamine (50 mg/day for one week followed by 100-150 mg/day) for 6 weeks. The majority of patients (76.7%) were stabilised on a dose of 100 mg/day for the duration of the study. There was a significant clinical response to fluvoxamine; more than 85% of patients were considered responders at the end of the study as assessed by their improvement on the Hamilton Depression Rating Scale (greater than or equal to50% reduction in score). These findings were confirmed by the Clinical Global Impression (CGI) - Severity scale, CGI Improvement scale and CGI - Quality of life scale. Fluvoxamine was well tolerated; the most common adverse events were dry mouth, nausea and vomiting, and constipation. In conclusion, fluvoxamine at a dose of 100-150 mg/day is effective, safe and well-tolerated in the treatment of people with depression.

语种: 英语
WOS记录号: WOS:000225872500004
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/51568
Appears in Collections:北京大学精神卫生研究所_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Suzhou Guangji Hosp, Suzhou, Peoples R China
2.Peking Univ, Inst Mental Hlth, Beijing, Peoples R China
3.Hongkou Dist Mental Hlth Ctr, Shanghai, Peoples R China
4.Nanjing Brain Hosp, Nanjing, Peoples R China
5.Shanghai Mental Hlth Ctr, Dept Psychiat, Shanghai 200030, Peoples R China
6.Capital Med Univ, Beijing Andling Hosp, Beijing, Peoples R China
7.Fudan Univ, Shanghai Zongshan Hosp, Shanghai 200433, Peoples R China
8.Tongji Univ, Shanghai Tongji Hosp, Mental & Somatol Dept, Shanghai 200092, Peoples R China

Recommended Citation:
Gu, NF,Cai, ZJ,Liang, S,et al. Fluvoxamine in the treatment of depression: results from a Chinese population[J]. PRIMARY CARE PSYCHIATRY,2004,9(3):89-94.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Gu, NF]'s Articles
[Cai, ZJ]'s Articles
[Liang, S]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Gu, NF]‘s Articles
[Cai, ZJ]‘s Articles
[Liang, S]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace